Kirk K. Calhoun - 09 Jun 2022 Form 4 Insider Report for NantHealth, Inc.

Reporting relationship: Director
Issuer ticker: N/A
Reported as of: 09 Jun 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 10 Jun 2022, 16:28:08 UTC
Prior SEC filing: 24 Feb 2022
Next SEC filing: 03 Oct 2023
Source filing: View source filing
Reporting owner signature: /s/ Brandon Villery, as Attorney-in-Fact

Key filing fact

Kirk K. Calhoun filed Form 4 for NantHealth, Inc. on 10 Jun 2022.

Key facts

This page summarizes Kirk K. Calhoun's Form 4 filing for NantHealth, Inc..
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 10 Jun 2022, 16:28.

Change

Previous filing in this sequence was filed on 24 Feb 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NHIQ transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +100,000
Change %
Price: $0.000000
Shares after: 100,000
Date: 09 Jun 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 100,000
Exercise price: $0.5823
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares subject to the option shall vest on the earlier of (i) the one year anniversary of the option grant date, or (ii) the day prior to the date of the Company's next annual meeting of the Company's stockholders, subject to the Reporting Person's continuing to be a Service Provider (as defined in the 2016 Equity Incentive Plan) through the vesting date.